#01 Entertainment
Mindy Kaling Reveals Real Reason Behind Body Transformation
Mindy Kaling opens up about her recent transformation focusing on embracing health over weight loss.
#02 Entertainment
Jonas Brothers to Launch Podcast for Fans
Jonas Brothers podcast launching on May 20th via iHeartMedia, featuring no topic off-limits.The Jonas Brothers are set to launch a new project that promises to engage their dedicated fan base.
#03 Pakistan
Modi’s ‘Statesman’ Image Shattered as Kashmiris Protest Oppression in Norway
Kashmiri protesters denounce Indian rule at Norwegian Parliament, challenging Modi's image as a statesman.
#04 pharmaceutical
KOALA Trial Opens for First-In-Human Study on KMA-Targeted CAR-T Therapy for Multiple Myeloma
KOOLA trial begins enrolling patients for the first-in-human study evaluating safety and early efficacy of KMA-targeting CAR-T therapy in multiple myeloma.
Health
Which Patients Benefit Most from Tirzepatide GLP-1 for Obesity and Obstructive Sleep Apnea?
New research reveals that while tirzepatide GLP-1 improves sleep apnea in obese individuals with OSA, not all patients benefit equally.
Health
Adolescents' Knowledge Linked to Higher STI/HIV Testing Rates
Study finds adolescents with better understanding of minor consent laws were more likely to seek HIV and STI testing, highlighting the importance of legal awareness for health care access.
Sports
Croatia Announce FIFA World Cup Squad Including Luka Modric
Croatia has unveiled its final roster for the upcoming FIFA World Cup, featuring renowned midfielder Luka Modric in his country's lineup for the group stage opener against England on June 17th.
pharmaceutical
AstraZeneca wins US approval for first‑in‑class Baxfendy in hypertension
AstraZeneca has announced that it has received approval from the US regulatory authorities for its novel medication, Baxdrostat, which will be marketed under the brand name Baxfendy.
pharmaceutical
Eli Lilly tops prominent rankings on pharma R&D performance
Eli Lilly takes top spots in a ranking of pharmaceutical innovators and investors, highlighting its dominance in drug industry with strong innovation and development metrics.